Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients (GCC1232)

Stopped early · Not applicable · Has a placebo group

Conditions studied: Breast Cancer, Colorectal Cancer

In brief

In this study the investigators will assess how useful and safe acupuncture is in easing the pain, tingling and numbness that is caused by chemotherapy. The researchers hope this will prevent the need to reduce the amount of chemotherapy a patient receives.

Key facts

Study ID

NCT01881932

Run by

University of Maryland, Baltimore

People needed

19

Starts

2013-02-01

Expected to finish

2015-04-01

Last updated by the study team

2019-11-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histologically proven stage I-III carcinoma of the breast OR histologically proven stage I-III colorectal carcinoma.
• Receiving adjuvant or neoadjuvant chemotherapy that includes a taxane or oxaliplatin.
• While on chemotherapy, develop greater than or equal to NCI-CTC grade 2 CIPN.
• Eastern Cooperative Oncology Group performance status 0-2.
• The patient is aware of the nature of his/her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form.

You may not qualify if…

• Prior acupuncture within one year of enrollment.
• Known metastatic (stage IV) breast or colorectal cancer involvement.
• Pre-existing peripheral neuropathy before chemotherapy is initiated
• Currently taking anti-neuropathy medication such as gabapentin, or pregabalin.

Where it is running

• University of Maryland Marlene & Stewart Greenebaum Cancer Center — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.